Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scionti Prostate Center is a specialized medical facility focused on the minimally invasive treatment of prostate cancer and benign prostatic hyperplasia (BPH). Led by Dr. Stephen Scionti, the center is a pioneer in the use of High-Intensity Focused Ultrasound (HIFU) and the TULSA-PRO procedure, which utilizes MRI-guided ultrasound to ablate prostate tissue. The center emphasizes focal therapy, aiming to treat cancerous lesions while preserving quality of life by minimizing common side effects such as impotence and incontinence. It serves as a leading destination for patients seeking advanced alternatives to traditional radical prostatectomy or radiation therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scionti Prostate Center.